Pharmaceutical Technologies (Parenteral and Transdermal Delivery) Flashcards

1
Q

What is the difference between epidural and intrathecal delivery?

A
  1. IT = Deliver into cerebrospinal fluid
  2. Epidural = Deliver into reservoir / lower back (Have to diffuse across epithelial layer)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the ebb and flow circulation of CSF like?

A

Direction is promoted by source and cilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the common barriers of parenteral delivery?

A
  1. BBB (Non-intrathecal only)
  2. Dilution / Distribution (Mainly non-intrathecal; Intrathecal within the CSF compartment)
  3. Reticuloendothelial system
  4. Metabolic enzymes
  5. Invasive
  6. Medical Professional needed
  7. Sterility is strict
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the advantages of parenteral delivery?

A

M: No hepatic first pass
A: Control dosage (Lower drug conc, toxicity)
D: Direct access to the brain
A: Sustained release (IM depot, IT reservoir)
Patient: Non-compliant, unconscious, dysphagic pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the three transporters in the BBB?

A
  1. Active efflux transporters (Pgp, BCRP, MRP)
  2. Carrier mediated transporters
  3. Receptor mediated transporters (Transcytosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the modified Lipinski’s rule of 5 for CNS?

A

MW < 450 Da
H bond donor < 3
H bond acceptor < 7
LogP 1-3
Unionizable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What excipients are needed for injection?

A

Diluent
Buffer salts
Tonicity adjusters
Stabilizers / Co-solvents

Minimally preservatives because it can complicate and cause brain inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What pH, tonicity and particle size considerations are required in injections?

A

pH 7.4 (IM: 3-11; SQ 3-6)

Tonicity 280-290 mOsm/L for large volume (Hypertonic preferred)

No visible particles size for IV (Less for SQ, IM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Examples of excipients for injections

A

Buffers = Acetate, citrate, phosphate, lactate

Preservative = Alcohol, Parabens

Tonicity adjuster = Mannitol, NaCl

Solvents = Ethanol, glycerol, PEG, propylene glycol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the primary anatomical barrier for drug delivery across the skin?

A

Stratum Corneum
- Brick and Mortar structure is an ordered and rigid bilayer structure
- Access occurs through intercellular lipid domains and appendages (follicles, ducts)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Differentiate transdermal and topical delivery

A

Transdermal = Deep penetration and Systemic Delivery (Usually Patch)

Topical = Superficial and Local Delivery (Usually gels and cream)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

5 advantages of transdermal delivery

A

o Controlled release (reservoirs, duration of contact) = Decreased dosing frequency
o No GI degradation/irritation
o Bypasses hepatic first pass effect
o Easy termination of input
o Non-invasive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

7 Barriers to transdermal delivery

A

o Variability between people and location of administration on body
o Stratum corneum: Slow absorption
o Skin irritation (interactions and removal)
o Could be removed by the patient
o Metabolic enzymes
o Blood brain barrier (via systemic delivery)
o Systemic side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the factors that affect transdermal delivery?

A

o Skin condition: age, disease, injury, site
o Skin thickness (thickness of diffusion layer)
o Hydration of skin (stratum corneum) - Natural or “manufactured” (occlusive: physical/chemical)
o Stimulation of the skin (phonophoresis/ ultrasound, iontophoresis, heat)
o Physicochemical properties of drug (lipophilicity, diffusion coefficient)
o Permeation enhancers - Reversible reduction in the barrier resistance of the stratum corneum without damaging viable cells
o Concentration gradient
o Area of contact between formulation and skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the modified Lipinsky’s rule for Transdermal Delivery

A

LogP 1-3 is the only difference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What excipients are needed in patches?

A

Preservatives

Solvents/co-solvents
= Ethanol, Propylene Glycol

Viscosity modifier
= CMC, HPMC, hyaluronate sodium, Alginate, Carbomer

Permeation enhancers
= Cyclodextrin, Glyceryl monooleate

Adhesives

17
Q

Drug release from the polymer matrices of transdermal patches depend on…

A

o Diffusion coefficient of drug
o Surface area
o Concentration
o Porosity/tortuosity of polymer matrix: Determined by intramolecular interactions (cross linking, hydrogen bonds)

18
Q

Three types of transdermal design

A
  1. Membrane (Thick): Drug in separate depot
  2. Matrix: Drug in polymer matrix
  3. Drug-in-adhesive: Drug in matrix and adhesive combined
19
Q

4 layers of a transdermal patch

A
  1. Backing layer (Protect drug)
  2. Membrane - Polymer matrix
  3. Adhesive - Silicone, rubber, perm enhancers
  4. Liner (Protect adhesive)
20
Q

What are 3 special considerations for transdermal patches?

A
  1. Release rate
    (Leaching into layers, temp, crystallinity)
  2. Adhesion strength
  3. Disposal